Brevan Howard Capital Management’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$974K Sell
8,153
-6,111
-43% -$801K 0.01% 912
2025
Q4
$1.94M Buy
14,264
+7,170
+101% +$1.03M 0.02% 490
2025
Q3
$1.05M Buy
7,094
+3,846
+118% +$533K ﹤0.01% 873
2025
Q2
$420K Buy
+3,248
New +$393K ﹤0.01% 1424
2024
Q3
Sell
-8,969
Closed -$1.22M 1485
2024
Q2
$1.22M Buy
8,969
+7,339
+450% +$998K 0.01% 323
2024
Q1
$211K Buy
+1,630
New +$197K ﹤0.01% 783

Other funds holding XYL

Brevan Howard Capital Management's XYL Position: Q1 2026 in Review

Brevan Howard Capital Management reduced its Xylem (XYL) stake by 43% in Q1 2026, selling an estimated $801K and leaving 8,153 shares worth $974K. The position accounts for 0.01% of the portfolio, ranked #912.

Brevan Howard Capital Management first reported a position in XYL in Q1 2024 and has held it in 6 quarters since. The position peaked at $1.94M in Q4 2025. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Brevan Howard Capital Management held 8,153 shares of Xylem worth $974K as of Q1 2026.
  • Brevan Howard Capital Management sold 6,111 Xylem shares in Q1 2026, an estimated $801K.
  • Xylem made up 0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #912 holding.
  • Brevan Howard Capital Management first reported a position in Xylem in Q1 2024 and has held it in 6 quarters since.
  • Brevan Howard Capital Management's Xylem position peaked at $1.94M in Q4 2025.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.